Psychotogenicity and N-methyl-D-aspartate receptor antagonism: Implications for neuroprotective pharmacotherapy
- 15 January 1997
- journal article
- review article
- Published by Elsevier in Biological Psychiatry
- Vol. 41 (2) , 135-144
- https://doi.org/10.1016/s0006-3223(96)00047-9
Abstract
No abstract availableKeywords
This publication has 59 references indexed in Scilit:
- Haloperidol-induced cell death—mechanism and protection with vitamin E in vitroNeuroReport, 1995
- Different binding affinities of NMDA receptor channel blockers in various brain regions—Indication of NMDA receptor heterogeneityNeuropharmacology, 1995
- A synaptic model of memory: long-term potentiation in the hippocampusNature, 1993
- The glial cell glutamate uptake carrier countertransports pH-changing anionsNature, 1992
- Open-channel block of N-methyl-D-aspartate (NMDA) responses by memantine: therapeutic advantage against NMDA receptor-mediated neurotoxicityJournal of Neuroscience, 1992
- Intra- and extracellular changes of amino acids in the cerebral cortex of the neonatal rat during hypoxic-ischemiaDevelopmental Brain Research, 1991
- Memantine is a potent blocker of N-methyl-D-aspartate (NMDA) receptor channelsEuropean Journal of Pharmacology, 1989
- Long-Term Neuropathological and Neurochemical Effects of Nucleus Basalis Lesions in the RatScience, 1987
- Elevation of the Extracellular Concentrations of Glutamate and Aspartate in Rat Hippocampus During Transient Cerebral Ischemia Monitored by Intracerebral MicrodialysisJournal of Neurochemistry, 1984
- Amantadine in Parkinson's diseaseNeurology, 1975